CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 52 enrolled
Drug / intervention
E-cigarette productdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04996940
NCT04996940N/ACompleted
CompareCT.gov

Comparative Acceptability of Tobacco and Menthol Flavored E-cigarettes Among Menthol Cigarette Smokers

University of Kansas Medical Center·interventional·Posted Aug 9, 2021·Updated Sep 13, 2023

In Brief

A clinical study evaluating E-cigarette product for Tobacco Use Disorder. Completed, enrolled 52 participants across 1 site.

Detailed Summary

The study is a randomized crossover trial. Current menthol smokers will complete a session with each flavor of an electronic cigarette: menthol and tobacco. The objective of this survey is to assess for flavor preference.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTobacco Use Disorder
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20222023202420252026
First PostedAug 9, 2021
Enrollment StartJun 20, 2021
Primary CompletionAug 15, 2021
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 4.9 years ago

Interventions

E-cigarette productdevice

Participants will be randomized 1:1 to e-cigarette flavor order either: 1. tobacco e-cigarette 2. menthol e-cigarette